Keynote Speakers

Richard Daneman

University of California, USA

Tae-Eun Park

Ulsan National Institute, South Korea

Dr. Tae-Eun Park is an assistant professor of Department of Biomedical Engineering at Ulsan National Institute of Science and Technology (UNIST) in Korea. She received her undergraduate degree in animal biotechnology in 2011 and her PhD in 2015 from Seoul National University. During PhD, she focused on development of blood-brain barrier (BBB) model and brain drug delivery systems mimicking rabies virus. She continued her postdoctoral studies at Wyss Institute in Harvard Medical School (2015-2017) under supervision of Prof. Donald E. Ingber. Her research area of interest lies in the development of organ mimetic systems for novel drug discovery and drug delivery systems using microfluidic and stem cell approaches. In particular, her research efforts focus on how to mimic and how to overcome blood-brain barrier for brain drug delivery.

Talk title : Brain drug delivery innovation through blood-brain barrier-on-a-chip technology

Andrew Yang

Gladstone Institutes & UCSF, USA

Andrew is an Assistant Professor at the Gladstone Institutes and UCSF. His lab develops new molecular approaches to understand the meaning, mechanisms, and therapeutic potential of protein and immune signaling across the brain’s unique barriers.

Talk title : Tracing proteomes across the blood-brain barrier

Invited Speakers

David Attwell

University College London, UK

Ayal Ben-Zvi

Hebrew University, Israel

Matthew Campbell

Trinity College Dublin, Ireland

Helge de Vries

UMC Amsterdam, Netherlands

Britta Engelhardt

Bern University, Switzerland

Krzysztof Kucharz

Copenhagen University, Denmark

Sarah Lutz

University of Illinois, USA

Ben Maoz

Tel Aviv University, Israel

Prof. Maoz is a faculty member at the Sagol School of Neuroscience and the Department of Biomedical Engineering at Tel Aviv University. Prof. Maoz did his Ph.D on nano-optics in the School of Chemistry at Tel Aviv. During his post-doctoral studies, at Harvard University, in Prof. Don Ingber and Kit Parker, he developed Organ-on-a-Chip platforms for studying human relevant physiology.
Prof. Maoz received number of prestigious fellowships, awards and honors, such as the Harvard-Wyss Technology Fellowship, Azrieli Fellowship for Academic Excellence and Leadership, ERC grant, recently he was chosen by “The Marker” as the most promising 40 under 40 and he gave a talk in the first metaverse TedX

Talk title : coming soon

Axel Montagne

Ediburgh University, UK

Dr Axel Montagne joined the UK Dementia Research Institute at Edinburgh in 2020. He completed his PhD degree at the University of Caen Normandy (France), followed by postdoctoral training at the University of Southern California (USC) in Los Angeles. His career has focused on how cerebrovascular dysfunctions contribute to neurodegeneration and dementia in both animal models and humans. In his UK DRI program, he combines molecular approaches with rodent non-invasive imaging, particularly MRI and microscopy techniques, to study the causes and effects of blood-brain barrier (BBB) dysfunction, with a particular focus on the Endothelium-Pericyte-Immune tripartite interactions, in the context of neurodegenerative disease. Dr Montagne’s work is supported by the UK DRI, principally funded by the UK Medical Research Council (MRC), and additional funding partners (Alzheimer’s Research UK, Alzheimer’s Society UK, and British Heart Foundation). In addition, Dr Montagne was awarded the 2021 SCOR Young European Researcher Prize for his research into Alzheimer’s disease and a MRC Career Development Award in 2022.

Talk title : Cerebrovascular Dynamics in Dementia: Unravelling the Tripartite Crosstalk between the Endothelium, Pericytes, and Microglia